medicalxpress.com·4 min read·hard
Silencing a brain receptor curbs cancer cachexia and boosts mouse survival
T
The Korea Advanced Institute of Science and Technology (KAIST)
✦AI Summary
Researchers at KAIST have identified a brain receptor mechanism that drives muscle loss in cancer patients, known as cancer cachexia. By blocking the GDF15-GFRAL signaling pathway, the team successfully extended survival in mouse models, offering a potential new therapeutic strategy.
by The Korea Advanced Institute of Science and Technology (KAIST)
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in